Yale Image Finder

Search the actual image content of 1,538,051 (and growing!) Open Access images and figures from PubMed Central.


Related Figures

Figure 2 Training grade.

Fig. (1) Ex-GRADE.

Figure 7 Survival by grade (--- grade 1; — grade ...

Figure 3 Pathological grades.

Figure 4 Grading scale.

Figure 3: Grading—low-grade malignant polyp (G2).

Figure 4: Grading—high-grade malignant polyp (G3).

Figure 4. Gallbladder grades and grade of surgeon.

Table 1 Grading System (Jahrsdoerfer [46])

Figure 4 Blastocyst grade III

Figure 2: Overall survival according to adjuvant radiotherapy for patients with low grade sarcomas (A) and high grade liposarcomas (B).

Image Text (High Precision): adjuvant overall radiotherapy surgery survival

Other Images from "Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy":

Figure 1 Overall survival of all patients.

Figure 2 Overall survival according to adjuvant r...

Figure 3 Overall survival of patients by prognost...

[Full Text] [PDF]


BackgroundPrognosis and optimal treatment strategies of liposarcoma have not been fully defined. The purpose of this study is to define the distinctive clinical features of liposarcomas by assessing prognostic factors.MethodsBetween January 1995 and May 2008, 94 liposarcoma patients who underwent surgical resection with curative intent were reviewed.ResultsFifty patients (53.2%) presented with well differentiated, 22 (23.4%) myxoid, 15 (16.0%) dedifferentiated, 5 (5.3%) round cell, and 2 (2.1%) pleomorphic histology. With the median 14 cm sized of tumor burden, about half of the cases were located in the retroperitoneum (46.8%). Seventy two (76.6%) patients remained alive with 78.1%, and 67.5% of the 5- and 10-year overall survival (OS) rates, respectively. Low grade liposarcoma (well differentiated and myxoid) had a significantly prolonged OS and disease free survival (DFS) with adjuvant radiotherapy when compared with those without adjuvant radiotherapy (5-year OS, 100% vs 66.3%, P = 0.03; 1-year DFS, 92.9% vs 50.0%, respectively, P = 0.04). Independent prognostic factors for OS were histologic variant (P = 0.001; HR, 5.1; 95% CI, 2.0 – 12.9), and margin status (P = 0.005; HR, 4.1; 95% CI, 1.6–10.5). We identified three different risk groups: group 1 (n = 66), no adverse factors; group 2, one or two adverse factors (n = 28). The 5-year OS rate for group 1, and 2 were 91.9%, 45.5%, respectively.ConclusionThe histologic subtype, and margin status were independently associated with OS, and adjuvant radiotherapy seems to confer survival benefit in low grade tumors. Our prognostic model for primary liposarcoma demonstrated distinct three groups of patients with good prognostic discrimination.

Search: Image Text (High Recall) Image Text (High Precision) Caption Abstract Title Full Text

All images and content copyright their respective owners. All else copyright ©2007-2008, Krauthammer Lab, Yale University.

Sign up for Yale Image Finder announcements: